Skip to content
Peptideworth

Ranked board

Semaglutide sellers, and whether what they say matches the trials

Semaglutide has more phase 3 evidence behind it than anything else in this category, which makes the gap between what the trials showed and what a seller says about them unusually easy to measure. Two companies here sell the same molecule and describe it completely differently. Only the semaglutide products are counted below.

By Grant Delaney, Research Editor

Disclosure: Some links on this site are affiliate or referral links. If you start a treatment or buy a product through them, we may earn a commission at no additional cost to you. Read our full disclosure.

What gets on this board

Every published review whose dispensed list includes a product we have graded as semaglutide — whether that is an FDA-approved Wegovy or Ozempic pen or a 503A compounded preparation. A company that sells a GLP-1 without naming the molecule is not on the board, because there is no claim about semaglutide to grade.

What decides the order

Ranked by how much of what each company sells is described accurately — the share of the products this board counts whose marketing claim matches the trials behind it. Ties go to the company with more matching claims, then to the one that names its pharmacy, then to the one that publishes a testing regime, and last of all to alphabetical order. Nothing is pinned, sponsored, or lifted into position.

What the grading found

11/21

Claims that match the trials

Across every one of these companies' semaglutide products that we have graded.

6/16

Name their pharmacy

A telehealth brand is almost never the pharmacy that fills the order.

0

Publish a readable certificate

Of every company reviewed on this site, not just those on this board.

The ranking

Every product counted here was graded against the published trials for that molecule, using the company's own words about it. The three counts below are that grading, and they are the ranking — there is no score, no weighting and no adjustment behind them.

Only semaglutide products are counted on this board. A company's sermorelin, NAD+ or glutathione claims do not move it up or down here — those are counted on the boards that cover them.

CompanyClaims vs. trialsDisclosesVisit
NovoCare Pharmacy

Checked August 2026

3/3100%

  • 0 reach past the trials
  • 0 with no trial behind them
Pharmacy named
Visit
Trellis Vitality

Checked August 2026

1/1100%

  • 0 reach past the trials
  • 0 with no trial behind them
Pharmacy namedTesting shown
Visit
Auren Rx

Checked August 2026

1/1100%

  • 0 reach past the trials
  • 0 with no trial behind them
Pharmacy named
Visit
Maximus

Checked August 2026

FDA letter — marketing

1/1100%

  • 0 reach past the trials
  • 0 with no trial behind them
Testing shown
Visit
Regenics

Checked August 2026

1/1100%

  • 0 reach past the trials
  • 0 with no trial behind them
Testing shown
Visit
Valhalla Vitality

Checked August 2026

1/1100%

  • 0 reach past the trials
  • 0 with no trial behind them
Testing shown
Visit
AgelessRx

Checked August 2026

1/250%

  • 1 reach past the trials
  • 0 with no trial behind them
Testing shown
Visit
Eden

Checked August 2026

FDA letter — marketing

1/250%

  • 1 reach past the trials
  • 0 with no trial behind them
Testing shown
Visit
Vyvron

Checked August 2026

1/250%

  • 0 reach past the trials
  • 1 with no trial behind them
Nothing published
Visit
Invigor Medical

Checked August 2026

0/10%

  • 1 reach past the trials
  • 0 with no trial behind them
Pharmacy namedTesting shown
Visit
PeptidesRx

Checked August 2026

0/10%

  • 1 reach past the trials
  • 0 with no trial behind them
Pharmacy namedTesting shown
Not linked
The Edit Health

Checked August 2026

0/10%

  • 1 reach past the trials
  • 0 with no trial behind them
Pharmacy namedTesting shown
Visit
Defy Medical

Checked August 2026

0/10%

  • 1 reach past the trials
  • 0 with no trial behind them
Nothing published
Visit
Joi + Blokes

Checked August 2026

FDA letter — marketing

0/10%

  • 1 reach past the trials
  • 0 with no trial behind them
Nothing published
Visit
Lighter You

Checked August 2026

0/10%

  • 1 reach past the trials
  • 0 with no trial behind them
Nothing published
Visit
Rehydra+ Wellness

Checked August 2026

0/10%

  • 1 reach past the trials
  • 0 with no trial behind them
Nothing published
Visit

How a claim is graded, and what moves a compound between evidence tiers, is on our methodology page.

What this board does not measure

Whether it works

A company can describe a weakly-evidenced product accurately and rank well here. What the evidence says about each molecule is on its own graded compound page, and the two questions are deliberately kept apart.

Clinical care

We read public pages. We have not been a patient of any of these companies, have not assessed a consultation, and publish no quality score of any kind.

Price

Prices appear on a review as a note where a company publishes one, and they are not part of this ranking. A cheaper company is not lower here and a dearer one is not higher.

Product quality

Not one company reviewed here publishes a certificate of analysis a customer can read. Until that changes, nothing on this site can tell you what is in a vial.

Considered, and not on this board

2 companies were inside this board's candidate net and did not meet its rule. Each one has a published review here, and none was left off for an unflattering result.

  • 1st Optimal

    Dispenses GLP-1 receptor agonist, molecule not named on any page that sells it — but nothing whose molecule is semaglutide, so it has no semaglutide claim of its own for us to grade.

  • Hone Health

    Dispenses Liraglutide — but nothing whose molecule is semaglutide, so it has no semaglutide claim of its own for us to grade.

Frequently asked questions

Is compounded semaglutide the same drug as Wegovy?

It is the same molecule and it is not the same product. Wegovy is an approved finished drug: FDA has reviewed that specific formulation, at those doses, for that indication, and it carries an NDC. A compounded preparation is made by a pharmacy against a prescription, is not FDA-approved, and is not reviewed by FDA for safety, effectiveness or quality. Both appear on this board, and each row says which one that company sells.

Why does a company selling the approved pen tend to rank higher?

Because an approved product comes with an approved label, and a label is a claim that has already been through the trials. It is much harder to overstate a drug when the sentence you are allowed to print was written from the evidence. That is a structural advantage, not a compliment, and the board shows it rather than correcting for it.

Nothing pinned

Ranked by how much of what each company sells is described accurately — the share of the products this board counts whose marketing claim matches the trials behind it. Ties go to the company with more matching claims, then to the one that names its pharmacy, then to the one that publishes a testing regime, and last of all to alphabetical order. Nothing is pinned, sponsored, or lifted into position.

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.